Sorry, you need to enable JavaScript to visit this website.

Node Banner

Oncology > Visual Symptom ALK+

Please note that some measures are designed to be used for clinical research for outcome
assessment and some measures are designed to be used as a screening tool.

VISUAL SYMPTOM ASSESSMENT QUESTIONNAIRE (VSAQ-ALK)

Click Thumbnail to Review

VISUAL SYMPTOM ASSESSMENT QUESTIONNAIRE (VSAQ-ALK)

Description and Context of Use
The Visual Symptom Assessment Questionnaire (VSAQ-ALK) is a self report measure that was developed to assess and better understand problems associated with eyesight. The VSAQ-ALK consists of seven items which assess the frequency, duration, bother, and impact of visual disturbances on activities daily living.
Population age range
Adults (18+)
Number of items
7
Recall Period
Past three weeks
Response Scales
Likert-type scale, Dichotomous: Yes/No
Administration Mode
Self-administered; Paper and pencil
Administration Time
10 minutes
References
Salgia R, Solomon BJ, Shaw AT, et al. Visual effects in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib. Journal of Clinical Oncology 2012 30:15_suppl, 7596-7596
Original Language
English (US)
*Select Available Language(s):
*Required
Select language
- Please check the fields in red.
- You must agree the Terms of Use.

Form Must
Be Completed